Medifast CEO Buys $178,724 in Company Stock

The purchase represents a significant increase in the CEO's stake in the weight management company.

Mar. 28, 2026 at 8:27am

Got story updates? Submit your updates here. ›

An extreme close-up of interlocking metal gears and machinery, conveying the tangible, industrial nature of financial institutions and corporate power structures.A CEO's substantial investment in his company's stock signals confidence in its future growth and stability.Baltimore Today

Medifast Inc. (NYSE:MED) CEO Daniel Chard acquired 17,678 shares of the company's stock on March 20th, 2026 at an average price of $10.11 per share. The total value of the transaction was $178,724.58, increasing Chard's direct ownership to 17,678 shares valued at the same amount.

Why it matters

Insider purchases can be seen as a positive signal, indicating the CEO's confidence in the company's future prospects. This transaction represents a substantial increase in Chard's stake, potentially signaling his belief that Medifast's stock is undervalued at current levels.

The details

The purchase was disclosed in a filing with the Securities and Exchange Commission. Following the transaction, Chard now directly owns 17,678 shares of Medifast stock, valued at approximately $178,724.58. This represents a significant increase from his previous direct ownership position.

  • The stock purchase occurred on Friday, March 20th, 2026.

The players

Daniel Chard

The CEO of Medifast Inc., a health and wellness company specializing in weight-loss and nutrition products.

Medifast Inc.

A publicly traded company (NYSE:MED) that provides clinically supported weight-loss, weight-management, and healthy living products and services.

Got photos? Submit your photos here. ›

What they’re saying

“This represents a significant increase in my stake in Medifast, reflecting my confidence in the company's long-term growth potential.”

— Daniel Chard, CEO, Medifast Inc.

What’s next

Investors will be closely watching Medifast's stock performance in the coming weeks and months to see if the CEO's purchase signals a potential turnaround for the company.

The takeaway

Insider purchases, especially by a company's CEO, can be seen as a positive sign for investors. Chard's substantial investment in Medifast stock suggests he believes the company is undervalued and has a bright future ahead.